Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100

NCT05684705 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections

Interventions

DRUG: BV100

Sponsor

BioVersys AG

Collaborators

[object Object]